Sep 29, 2016 21:04 pm UTC| Business
CHARLOTTE, N.C., Sept. 29, 2016 -- Crescent Communities, LLC (the “Company”) announced today that the Company and its wholly owned subsidiary, Crescent Ventures, Inc. (together with the Company, the “Issuers”), have...
Douglas Dynamics Recognized as One of FORTUNE’S “100 Fastest-Growing Public Companies”
Sep 29, 2016 21:00 pm UTC| Business
MILWAUKEE, Sept. 29, 2016 -- Douglas Dynamics, Inc. (NYSE:PLOW), North America’s premier manufacturer of vehicle attachments and equipment, announced today that it has been named to the 2016 FORTUNE magazine list of the...
WSFS Bank Named 2016 Bank & Thrift “Sm-All Star” by Sandler O’Neill + Partners
Sep 29, 2016 20:54 pm UTC| Business
WILMINGTON, Del., Sept. 29, 2016 -- WSFS Financial Corporation (NASDAQ:WSFS), the parent company of WSFS Bank, today announced that WSFS Bank was named a 2016 Bank Thrift “Sm-All Star” by Sandler O’Neill + Partners....
Sep 29, 2016 20:53 pm UTC| Business
NEW YORK, Sept. 29, 2016 -- Och-Ziff Capital Management Group LLC (NYSE:OZM) today announced that it has reached settlements with the Department of Justice (DOJ) and the Securities and Exchange Commission (SEC),...
Kimball Electronics, Inc. Announces Stock Repurchase Plan
Sep 29, 2016 20:15 pm UTC| Business
JASPER, Ind., Sept. 29, 2016 -- Kimball Electronics, Inc. (NASDAQ:KE), (the “Company”), today announced that the Board of Directors (the “Board”) of Kimball Electronics, Inc., at a September 29, 2016 meeting, authorized...
Sep 29, 2016 20:15 pm UTC| Business
MENLO PARK, Calif., Sept. 29, 2016 -- Exponent, Inc. (Nasdaq:EXPO), today announced that it will report third quarter of fiscal year 2016 financial results for the period ended September 30, 2016 following the close of...
Cempra Announces Anti-NASH Effects of Solithromycin: Interim Results From Phase 2 Study
Sep 29, 2016 20:15 pm UTC| Business
— Pre/post treatment biopsies confirm mean NAS reduction of 1.3 points after 90 days of treatment with solithromycin — — All six patients showed ALT reductions after 90 days of treatment with solithromycin — —...